Literature DB >> 9041397

Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis.

B Hjelle1, S Jenison, N Torrez-Martinez, B Herring, S Quan, A Polito, S Pichuantes, T Yamada, C Morris, F Elgh, H W Lee, H Artsob, R Dinello.   

Abstract

To develop a rapid antibody test for Sin Nombre hantavirus (SNV) infection for diagnosis of hantavirus pulmonary syndrome (HPS) in field settings where advanced instrumentation is not available, a strip immunoblot assay bearing four immobilized antigens for SNV and a recombinant nucleocapsid protein antigen of Seoul hantavirus (SEOV) was prepared. The SNV antigens included a full-length recombinant-expressed nucleocapsid (N) protein (rN), a recombinant-expressed G1 protein (residues 35 to 117), and synthetic peptides derived from N (residues 17 to 59) and G1 (residues 55 to 88). On the basis of the observed reactivities of hantavirus-infected patient and control sera, we determined that a positive assay requires reactivity with SNV or SEOV rN antigen and at least one other antigen. Isolated reactivity to either viral rN antigen is indeterminate, and any pattern of reactivity that does not include reactivity to an rN antigen is considered indeterminate but is unlikely to represent hantavirus infection. Fifty-eight of 59 samples from patients with acute SNV-associated HPS were positive according to these criteria, and one was initially indeterminate. Four of four samples from patients with HPS due to other hantaviruses were positive, as were most samples from patients with SEOV and Puumala virus infections. Of 192 control serum samples, 2 (1%) were positive and 2 were indeterminate. Acute SNV infection was distinguishable from remote SNV infection or infection with hantaviruses other than SNV by the presence of G1 peptide antigen reactivities in the former. The strip immunoblot assay shows promise for the detection of SNV antibodies early in the course of HPS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041397      PMCID: PMC229635          DOI: 10.1128/jcm.35.3.600-608.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Frequency of indeterminate western blot tests in healthy adults at low risk for human immunodeficiency virus infection. The NIAID AIDS Vaccine Clinical Trails Network.

Authors:  K Midthun; L Garrison; M L Clements; H Farzadegan; B Fernie; T Quinn
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

2.  Antigenicity of hantavirus nucleocapsid proteins expressed in E. coli.

Authors:  P Gött; L Zöller; S Yang; R Stohwasser; E K Bautz; G Darai
Journal:  Virus Res       Date:  1991-03       Impact factor: 3.303

3.  Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.

Authors:  S Pichuantes; L M Babé; P J Barr; D L DeCamp; C S Craik
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

4.  Immunoglobulin G subclass responses against the structural components of Puumala virus.

Authors:  A Lundkvist; S Björsten; B Niklasson
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Recombinant HIV1 protease secreted by Saccharomyces cerevisiae correctly processes myristylated gag polyprotein.

Authors:  S Pichuantes; L M Babé; P J Barr; C S Craik
Journal:  Proteins       Date:  1989

6.  Characterization of Dobrava virus: a Hantavirus from Slovenia, Yugoslavia.

Authors:  T Avsic-Zupanc; S Y Xiao; R Stojanovic; A Gligic; G van der Groen; J W LeDuc
Journal:  J Med Virol       Date:  1992-10       Impact factor: 2.327

7.  Comparison of the kinetics of Puumala virus specific IgM and IgG antibody responses in nephropathia epidemica as measured by a recombinant antigen-based enzyme-linked immunosorbent assay and an immunofluorescence test.

Authors:  F Elgh; G Wadell; P Juto
Journal:  J Med Virol       Date:  1995-02       Impact factor: 2.327

8.  Fatal illness associated with a new hantavirus in Louisiana.

Authors:  A S Khan; C F Spiropoulou; S Morzunov; S R Zaki; M A Kohn; S R Nawas; L McFarland; S T Nichol
Journal:  J Med Virol       Date:  1995-07       Impact factor: 2.327

9.  Phylogenetically distinct hantavirus implicated in a case of hantavirus pulmonary syndrome in the northeastern United States.

Authors:  B Hjelle; J Krolikowski; N Torrez-Martinez; F Chavez-Giles; C Vanner; E Laposata
Journal:  J Med Virol       Date:  1995-05       Impact factor: 2.327

10.  Isolation of black creek canal virus, a new hantavirus from Sigmodon hispidus in Florida.

Authors:  P E Rollin; T G Ksiazek; L H Elliott; E V Ravkov; M L Martin; S Morzunov; W Livingstone; M Monroe; G Glass; S Ruo
Journal:  J Med Virol       Date:  1995-05       Impact factor: 2.327

View more
  34 in total

1.  Confirmation of Choclo virus as the cause of hantavirus cardiopulmonary syndrome and high serum antibody prevalence in Panama.

Authors:  Randin Nelson; Raul Cañate; Juan Miguel Pascale; Jerry W Dragoo; Blas Armien; Anibal G Armien; Frederick Koster
Journal:  J Med Virol       Date:  2010-09       Impact factor: 2.327

2.  Hantavirus fever without pulmonary syndrome in Panama.

Authors:  Blas Armien; Juan M Pascale; Carlos Muñoz; Jamileth Mariñas; Heydy Núñez; Milagro Herrera; José Trujillo; Deyanira Sánchez; Yaxelis Mendoza; Brian Hjelle; Frederick Koster
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

3.  Infections by Leptospira interrogans, Seoul virus, and Bartonella spp. among Norway rats (Rattus norvegicus) from the urban slum environment in Brazil.

Authors:  Federico Costa; Fleur Helena Porter; Gorete Rodrigues; Helena Farias; Marcus Tucunduva de Faria; Elsio A Wunder; Lynn M Osikowicz; Michael Y Kosoy; Mitermayer Galvão Reis; Albert I Ko; James E Childs
Journal:  Vector Borne Zoonotic Dis       Date:  2013-12-20       Impact factor: 2.133

4.  Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity.

Authors:  Jonas Schmidt; Burkhard Jandrig; Boris Klempa; Kumiko Yoshimatsu; Jiro Arikawa; Helga Meisel; Matthias Niedrig; Christian Pitra; Detlev H Krüger; Rainer Ulrich
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

5.  Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus.

Authors:  Tony Schountz; Joseph Prescott; Ann C Cogswell; Lauren Oko; Katy Mirowsky-Garcia; Alejandra P Galvez; Brian Hjelle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

6.  Antigenic characterization of Hantaan and Seoul virus nucleocapsid proteins expressed by recombinant baculovirus: application of a truncated protein, lacking an antigenic region common to the two viruses, as a serotyping antigen.

Authors:  M Morii; K Yoshimatsu; J Arikawa; G Zhou; H Kariwa; I Takashima
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

7.  Convalescent pulmonary dysfunction following hantavirus pulmonary syndrome in Panama and the United States.

Authors:  Fernando Gracia; Blas Armien; Steven Q Simpson; Carlos Munoz; Candida Broce; Juan Miguel Pascale; Frederick Koster
Journal:  Lung       Date:  2010-06-04       Impact factor: 2.584

8.  Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome.

Authors:  Paula Godoy; Delphine Marsac; Elias Stefas; Pablo Ferrer; Nicole D Tischler; Karla Pino; Pablo Ramdohr; Pablo Vial; Pablo D T Valenzuela; Marcela Ferrés; Francisco Veas; Marcelo López-Lastra
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

9.  Experimental evidence for reduced rodent diversity causing increased hantavirus prevalence.

Authors:  Gerardo Suzán; Erika Marcé; J Tomasz Giermakowski; James N Mills; Gerardo Ceballos; Richard S Ostfeld; Blas Armién; Juan M Pascale; Terry L Yates
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

10.  Rapid field immunoassay for detecting antibody to Sin Nombre virus in deer mice.

Authors:  Tony Schountz; Charles H Calisher; Tiffany R Richens; Audrey A Rich; Jeffrey B Doty; Mark T Hughes; Barry J Beaty
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.